drugset / Trial / NCT00741845
Prevention of Persistence of Bacterial Vaginosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This purpose of this study will be to conduct a double-blind, randomized, controlled clinical trial to determine the association between intravaginal high dose metronidazole (750mg), intravaginal high dose metronidazole combined with an antifungal agent(750mg metronidazole + 200mg miconazole) and low dose (37.5mg) intravaginal metronidazole, with the rate of persistent bacterial vaginosis.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metronidazole | Small molecule | 37.5 mg | Other |
| Comparator | Metronidazole | Small molecule | 750 mg | Other |
| Comparator | Miconazole | Small molecule | 200 mg | — |